Solasodine rhamnosyl glycosides cause apoptosis in cancer cells. Do they also prime the immune system resulting in long-term protection against cancer?

@article{Cham2012SolasodineRG,
  title={Solasodine rhamnosyl glycosides cause apoptosis in cancer cells. Do they also prime the immune system resulting in long-term protection against cancer?},
  author={Bill Elliot Cham and Tania Robyn Chase},
  journal={Planta medica},
  year={2012},
  volume={78 4},
  pages={349-53}
}
Solasodine rhamnosyl glycosides (SRGs) induce apoptosis in a wide variety of cancer cells and are more effective than many well-established anticancer agents. Combination therapy of SRGs with cisplatin treats cisplatin-resistant cells such as lung cancer and breast cancer cells. Anticancer therapies with SRGs have been used intravenously, intraperitoneally, intralesionally, orally, and topically. Data is now presented that in addition to apoptosis and, perhaps as a consequence thereof, SRGs… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.